November 05, 2009

Sanofi-aventis announces proposal for staged closure of Dagenham manufacturing site

• Download the Press Release dated November 5, 2009 (PDF, 35Kb)

September 28, 2009

Multaq® (dronedarone) Recommended for Approval in the European Union

Sanofi-aventis announced today that the committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq® (dronedarone - 400mg Tablets).

• Download the Press Release dated September 28, 2009 (PDF, 48Kb)

August 28, 2009

Sanofi-aventis announces new UK leadership structure

Sanofi-aventis is pleased to announce its new UK leadership structure which will shape the company's future direction enabling it to be more customer and patient focused.

• Download the Press Release dated August 28, 2009 (PDF, 133Kb)

June 30, 2009

Sanofi-aventis presents New R&D Model Project to boost Innovation

Sanofi-aventis presented today its new Research and Development model project. The model, which aims to transform R&D and increase innovation, is the first pillar of the Group's new strategy which was presented in February 2009 by Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis.

• Download the Press Release dated June 30, 2009 (PDF, 80Kb)

June 29, 2009

Sanofi-aventis stands behind the safety of Lantus®

Sanofi-aventis has just been made aware of the data associated with a retrospective follow-up of four patient registries. The results of these data clearly show that no definitive conclusions can be drawn regarding a possible casual relationship between Lantus® (insulin glargine) use and the occurence of malignancies, as the authors of the study point out.

• Download the Press Release dated June 29, 2009 (PDF, 75Kb)

June 19, 2009

Call for Common Action to Fight the Influenza Pandemic

Christopher A. Viehbacher reaffirmed sanofi-aventis' commitment to access to health during the Pacific Health Summit in Seattle. Sanofi-aventis intends to donate 100 million doses of influenza vaccine to WHO to face the pandemic.

• Download the Press Release dated June 19, 2009 (PDF, 89Kb)

May 15, 2009

Sanofi-aventis introduces sanofi-aventis TV "A window on our company"

Paris, France – May 15, 2009 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the launch of sanofi-aventis TV, a new webTV aimed at providing information about the company’s wide range of patient-focused businesses, social responsibilities, and employee activities. The site will also provide perspectives on the company’s mission and strategic directions.

• Download the Press Release dated May 15, 2009 (PDF, 96Kb)

April 22, 2009

Sanofi-aventis Donates Medical Equipment to Zundao Community Hospital

Company Remains Committed to Post-earthquake Rebuilding Efforts
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) today donated medical equipment to Zundao Community Hospital, which marks the first permanent hospital rebuilt after the tragic earthquake on May 12, 2008.

• Download the Press Release dated April 22, 2009 (PDF, 74Kb)

March 09, 2009

Jérôme Contamine appointed Chief Financial Officer

Paris, France - March 9, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that Jérôme Contamine is appointed Executive Vice President, Chief Financial Officer (CFO) of sanofi-aventis, effective March 16, 2009.

• Download the Press Release dated March 09, 2009 (PDF, 114Kb)

February 25, 2009

Steve Oldfield appointed General Manager, sanofi-aventis UK

Sanofi-aventis announced today that Steve Oldfield will become General Manager, sanofi-aventis UK effective June 2009

• Download the Press Release dated February 25, 2009 (PDF, 56Kb)